Morgan Stanley’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $450M | Sell |
6,374,717
-2,158,156
| -25% | -$117M | 0.02% | 621 |
|
|
2026
Q1 | $446M | Buy |
8,532,873
+187,459
| +2% | +$11.3M | 0.03% | 581 |
|
|
2025
Q4 | $491M | Buy |
8,345,414
+1,107,536
| +15% | +$67.3M | 0.03% | 540 |
|
|
2025
Q3 | $403M | Buy |
7,237,878
+658,935
| +10% | +$35.3M | 0.02% | 602 |
|
|
2025
Q2 | $338M | Buy |
6,578,943
+859,403
| +15% | +$43.2M | 0.02% | 639 |
|
|
2025
Q1 | $335M | Buy |
5,719,540
+961,015
| +20% | +$65.1M | 0.02% | 619 |
|
|
2024
Q4 | $343M | Buy |
4,758,525
+100,934
| +2% | +$7.41M | 0.02% | 610 |
|
|
2024
Q3 | $372M | Buy |
4,657,591
+246,895
| +6% | +$18.6M | 0.03% | 577 |
|
|
2024
Q2 | $316M | Buy |
4,410,696
+220,418
| +5% | +$16.2M | 0.02% | 611 |
|
|
2024
Q1 | $295M | Buy |
4,190,278
+102,183
| +2% | +$7.31M | 0.02% | 629 |
|
|
2023
Q4 | $315M | Buy |
4,088,095
+782,269
| +24% | +$51.5M | 0.03% | 577 |
|
|
2023
Q3 | $225M | Buy |
3,305,826
+143,716
| +5% | +$11.4M | 0.02% | 647 |
|
|
2023
Q2 | $258M | Sell |
3,162,110
-22,072
| -0.7% | -$1.77M | 0.03% | 617 |
|
|
2023
Q1 | $236M | Buy |
3,184,182
+201,552
| +7% | +$15.5M | 0.03% | 627 |
|
|
2022
Q4 | $247M | Buy |
2,982,630
+2,130,678
| +250% | +$169M | 0.03% | 601 |
|
|
2022
Q3 | $60.5M | Sell |
851,952
-70,464
| -8% | -$6.09M | 0.01% | 1185 |
|
|
2022
Q2 | $79.9M | Buy |
922,416
+499,312
| +118% | +$46.8M | 0.01% | 1065 |
|
|
2022
Q1 | $45.8M | Buy |
423,104
+42,444
| +11% | +$4.38M | 0.01% | 1360 |
|
|
2021
Q4 | $49.2M | Sell |
380,660
-81,224
| -18% | -$9.96M | 0.01% | 1347 |
|
|
2021
Q3 | $56M | Buy |
461,884
+134,648
| +41% | +$16.4M | 0.01% | 1221 |
|
|
2021
Q2 | $36.8M | Buy |
327,236
+168,388
| +106% | +$17.7M | ﹤0.01% | 1555 |
|
|
2021
Q1 | $15.2M | Sell |
158,848
-150,880
| -49% | -$13.8M | ﹤0.01% | 2214 |
|
|
2020
Q4 | $24.6M | Buy |
309,728
+175,516
| +131% | +$12.7M | ﹤0.01% | 1614 |
|
|
2020
Q3 | $8.31M | Sell |
134,212
-8,012
| -6% | -$521K | ﹤0.01% | 2198 |
|
|
2020
Q2 | $9.39M | Sell |
142,224
-286,452
| -67% | -$17.2M | ﹤0.01% | 2030 |
|
|
2020
Q1 | $20.3M | Buy |
428,676
+205,404
| +92% | +$10.3M | 0.01% | 1261 |
|
|
2019
Q4 | $12.3M | Buy |
223,272
+86,332
| +63% | +$4.53M | ﹤0.01% | 2181 |
|
|
2019
Q3 | $6.7M | Sell |
136,940
-39,496
| -22% | -$1.98M | ﹤0.01% | 2553 |
|
|
2019
Q2 | $9.2M | Sell |
176,436
-55,484
| -24% | -$2.8M | ﹤0.01% | 2255 |
|
|
2019
Q1 | $11.5M | Buy |
231,920
+84,264
| +57% | +$3.79M | ﹤0.01% | 1906 |
|
|
2018
Q4 | $5.34M | Sell |
147,656
-186,156
| -56% | -$7.78M | ﹤0.01% | 2827 |
|
|
2018
Q3 | $17M | Sell |
333,812
-166,968
| -33% | -$7.4M | ﹤0.01% | 1837 |
|
|
2018
Q2 | $18.5M | Buy |
500,780
+137,680
| +38% | +$5.26M | 0.01% | 1710 |
|
|
2018
Q1 | $13.7M | Sell |
363,100
-94,280
| -21% | -$3.33M | ﹤0.01% | 2040 |
|
|
2017
Q4 | $14.8M | Buy |
457,380
+42,088
| +10% | +$1.34M | ﹤0.01% | 1975 |
|
|
2017
Q3 | $12.6M | Buy |
415,292
+149,836
| +56% | +$4.45M | ﹤0.01% | 2051 |
|
|
2017
Q2 | $7.8M | Sell |
265,456
-95,048
| -26% | -$2.6M | ﹤0.01% | 2412 |
|
|
2017
Q1 | $9.16M | Buy |
360,504
+19,952
| +6% | +$515K | ﹤0.01% | 2286 |
|
|
2016
Q4 | $8.75M | Buy |
340,552
+157,096
| +86% | +$4.13M | ﹤0.01% | 2395 |
|
|
2016
Q3 | $5.02M | Sell |
183,456
-31,024
| -14% | -$852K | ﹤0.01% | 2652 |
|
|
2016
Q2 | $6.05M | Buy |
214,480
+91,128
| +74% | +$2.34M | ﹤0.01% | 2431 |
|
|
2016
Q1 | $2.92M | Buy |
123,352
+3,496
| +3% | +$77K | ﹤0.01% | 3021 |
|
|
2015
Q4 | $2.7M | Sell |
119,856
-102,524
| -46% | -$2.34M | ﹤0.01% | 3228 |
|
|
2015
Q3 | $5.14M | Sell |
222,380
-68,360
| -24% | -$1.71M | ﹤0.01% | 2632 |
|
|
2015
Q2 | $7.16M | Buy |
290,740
+28,808
| +11% | +$719K | ﹤0.01% | 2453 |
|
|
2015
Q1 | $6.57M | Sell |
261,932
-24,028
| -8% | -$571K | ﹤0.01% | 2494 |
|
|
2014
Q4 | $6.61M | Sell |
285,960
-53,244
| -16% | -$1.22M | ﹤0.01% | 2454 |
|
|
2014
Q3 | $7.93M | Buy |
339,204
+109,412
| +48% | +$2.56M | ﹤0.01% | 2238 |
|
|
2014
Q2 | $5.32M | Buy |
229,792
+58,900
| +34% | +$1.3M | ﹤0.01% | 2626 |
|
|
2014
Q1 | $3.65M | Sell |
170,892
-1,476,416
| -90% | -$33.2M | ﹤0.01% | 2879 |
|
|
2013
Q4 | $39M | Sell |
1,647,308
-1,203,312
| -42% | -$26.1M | 0.02% | 879 |
|
|
2013
Q3 | $57.1M | Buy |
2,850,620
+210,192
| +8% | +$3.99M | 0.03% | 625 |
|
|
2013
Q2 | $45.6M | Buy |
+2,640,428
| New | +$43.8M | 0.02% | 690 |
|
Other funds holding TECH
HI
RCG
Morgan Stanley's TECH Position: Q2 2026 in Review
Morgan Stanley reduced its Bio-Techne (TECH) stake by 25% in Q2 2026, selling an estimated $117M and leaving 6,374,717 shares worth $450M. The position accounts for 0.02% of the portfolio, ranked #621.
Morgan Stanley first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $491M in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Morgan Stanley held 6,374,717 shares of Bio-Techne worth $450M as of Q2 2026.
- Morgan Stanley sold 2,158,156 Bio-Techne shares in Q2 2026, an estimated $117M.
- Bio-Techne made up 0.02% of Morgan Stanley's portfolio in Q2 2026, its #621 holding.
- Morgan Stanley first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Bio-Techne position peaked at $491M in Q4 2025.
- 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.